As of Feb 11
| -2.47 / -2.80%|
The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 120.00, with a high estimate of 146.00 and a low estimate of 104.00. The median estimate represents a +39.88% increase from the last price of 85.79.
The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.